SPARC — Sun Pharma Advanced Research Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapTurnaround

Annual balance sheet for Sun Pharma Advanced Research Co, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	157	4,066	1,571	19.6	26.2
Net Total Accounts Receivable
Net Total Receivables	519	439	1,060	187	139
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	712	4,550	2,694	262	18,624
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	951	1,073	1,086	993	857
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,801	8,301	5,150	3,355	21,709
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,714	1,789	2,651	3,742	7,541
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	2,489	3,174	3,893	5,525	8,320
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	312	5,128	1,258	-2,169	13,388
Total Liabilities & Shareholders' Equity	2,801	8,301	5,150	3,355	21,709
Total Common Shares Outstanding